CDH2 and breast cancer: They examined seven pooled epithelial transcripts (Keratins 5, 7, 8, 18, and 19; EpCAM (epithelial cellular adhesion molecule) and E-cadherin) and three mesenchymal transcripts (fibronectin, N-cadherin, and SERPINE1/PAI1 (serpin peptidase inhibitor, clade E)) in 11 human breast cancer specimens.